| __timestamp | Jazz Pharmaceuticals plc | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 85181000 | 13673000 |
| Thursday, January 1, 2015 | 135253000 | 14358000 |
| Friday, January 1, 2016 | 162297000 | 12203000 |
| Sunday, January 1, 2017 | 198442000 | 18125000 |
| Monday, January 1, 2018 | 226616000 | 17071000 |
| Tuesday, January 1, 2019 | 299726000 | 20018000 |
| Wednesday, January 1, 2020 | 335375000 | 32788000 |
| Friday, January 1, 2021 | 505748000 | 44966000 |
| Saturday, January 1, 2022 | 590453000 | 311681000 |
| Sunday, January 1, 2023 | 849658000 | 77707000 |
Unveiling the hidden dimensions of data
In the competitive landscape of pharmaceuticals, research and development (R&D) expenses are a key indicator of a company's commitment to innovation. Over the past decade, Jazz Pharmaceuticals plc has consistently outpaced Lantheus Holdings, Inc. in R&D spending. From 2014 to 2023, Jazz Pharmaceuticals increased its R&D expenses by nearly 900%, peaking in 2023. This surge reflects their aggressive pursuit of new therapies and market expansion.
Conversely, Lantheus Holdings, while showing a significant increase in 2022, has maintained a more conservative R&D budget, with a notable spike of over 2000% in 2022. This suggests a strategic pivot or breakthrough development during that year. The data highlights the contrasting strategies of these two companies: Jazz's steady growth versus Lantheus's targeted investments. As the pharmaceutical industry evolves, these R&D trends will likely shape their future trajectories.
Research and Development Investment: Novartis AG vs Jazz Pharmaceuticals plc
Pfizer Inc. vs Jazz Pharmaceuticals plc: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Gilead Sciences, Inc. vs Lantheus Holdings, Inc.
Research and Development: Comparing Key Metrics for Alnylam Pharmaceuticals, Inc. and Lantheus Holdings, Inc.
Analyzing R&D Budgets: Incyte Corporation vs Jazz Pharmaceuticals plc
Bio-Techne Corporation vs Jazz Pharmaceuticals plc: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Supernus Pharmaceuticals, Inc.
Analyzing R&D Budgets: Halozyme Therapeutics, Inc. vs Lantheus Holdings, Inc.
Lantheus Holdings, Inc. or Corcept Therapeutics Incorporated: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Lantheus Holdings, Inc. and PTC Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Lantheus Holdings, Inc. and Catalyst Pharmaceuticals, Inc.
R&D Spending Showdown: Lantheus Holdings, Inc. vs MiMedx Group, Inc.